Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Personalizing Sleep Interventions to Prevent Type 2 Diabetes in Community Dwelling Adults With Pre-Diabetes

NCT03398902
completednot_applicable

Effect of Sleep Restriction on Adipose Tissue and Skeletal Muscle Insulin Sensitivity

NCT04286451
completednot_applicable

Effects of Sleep Restriction on BAT Activation in Humans

NCT02770118
completednot_applicable

Sleep Restriction and Energy Expenditure

NCT01751581

Clinical Trials (4)

Showing 4 of 4 trials
NCT03398902Not Applicable

Personalizing Sleep Interventions to Prevent Type 2 Diabetes in Community Dwelling Adults With Pre-Diabetes

Completed
NCT04286451Not Applicable

Effect of Sleep Restriction on Adipose Tissue and Skeletal Muscle Insulin Sensitivity

Completed
NCT02770118Not Applicable

Effects of Sleep Restriction on BAT Activation in Humans

Completed
NCT01751581Not Applicable

Sleep Restriction and Energy Expenditure

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4